Latest News

The Yale Organ Transplantation and Immunology program completed its 750th liver transplant on Dec. 10, 2025. The landmark procedure reflects continued growth in procedural volume and strengthens the program’s trajectory toward designation as a nationally recognized Center of Excellence.

Members of the Center for Breast Cancer and the Hematology Program at Yale Cancer Center and Smilow Cancer Hospital recently presented their latest groundbreaking research on two national stages. First at the annual American Society of Hematology (ASH) meeting, followed by the annual San Antonio Breast Cancer Symposium (SABCS).

For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there.

Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.

Yale scientists found molecular switches that trick the activity of neutrophils and minimize their collateral damage during a heart attack.

A new study from the Braddock Laboratory at Yale School of Medicine sheds light on the pathogenesis of two debilitating spinal disorders prevalent in the aging population – ossification of the posterior longitudinal ligament (OPLL) and diffuse idiopathic skeletal hyperostosis (DISH), and presents potential groundbreaking therapy.

Physicians, scientists, and trainees from Yale Cancer Center and Smilow Cancer Hospital attended the 67th annual meeting of the American Society of Hematology in Orlando, FL, December 6-9, 2025 to present the latest advances in hematological research and clinical care from Yale.

In the field of stroke research, Yale works to bridge the gap between preclinical and clinical, increasing the likelihood that new treatments work in patients.

Advances in facial transplantation expand possibilities, offering life-changing options for patients with severe facial injuries.